Testing effectiveness (Phase 2)Ended earlyNCT02010203What this trial is testingHS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBTWho this might be right forBladder Cancer Heat Biologics 104
Testing effectiveness (Phase 2)UnknownNCT05515042What this trial is testingPhase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults.Who this might be right forCOVID-19 The Aurum Institute NPC 694
Early research (Phase 1)Study completedNCT01354379What this trial is testingSafety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by SprayerWho this might be right forHealthy Adult Volunteers NanoBio Corporation 125
Large-scale testing (Phase 3)Study completedNCT01125527What this trial is testingImmunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy ChildrenWho this might be right forHaemophilus Influenzae Type b (Hib) Infection Novartis Vaccines 700
Testing effectiveness (Phase 2)Active Not RecruitingNCT03970746What this trial is testingSafety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLCWho this might be right forNon Small Cell Lung Cancer PDC*line Pharma SAS 73
Testing effectiveness (Phase 2)Study completedNCT02074046What this trial is testingSafety Study of Cancer Stem Cell Vaccine to Treat Pancreatic CancerWho this might be right forNeoplasms, Pancreas Fuda Cancer Hospital, Guangzhou 40
Large-scale testing (Phase 3)UnknownNCT02858570What this trial is testingConjugate Vaccine Against Meningococcus C a Brazilian ProjectWho this might be right forSerogroup C Meningococcal Meningitis The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 1,644
Not applicableLooking for participantsNCT07321808What this trial is testingImmunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail PatientsWho this might be right forImmunocompromised Patients Fondazione IRCCS Policlinico San Matteo di Pavia 300
Early research (Phase 1)Study completedNCT00290147What this trial is testingSafety and Immunogenicity Study of a Dengue Virus DNA VaccineWho this might be right forDengue U.S. Army Medical Research and Development Command 22
Post-approval studies (Phase 4)UnknownNCT04638985What this trial is testingEvaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMRWho this might be right forVaccine China National Biotec Group Company Limited 600
Post-approval studies (Phase 4)Study completedNCT01859143What this trial is testingStudy to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in AdultsWho this might be right forInfluenzaHealthy MedImmune LLC 300
Testing effectiveness (Phase 2)Study completedNCT00419133What this trial is testingImmunogenicity of One Versus Two Doses of Killed Oral Cholera VaccineWho this might be right forCholeraDiarrheaVibrio Infections International Vaccine Institute 160
Testing effectiveness (Phase 2)Study completedNCT04350138What this trial is testingSafety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal InfectionWho this might be right forGonococcal Infection National Institute of Allergy and Infectious Diseases (NIAID) 2,606
Large-scale testing (Phase 3)Active Not RecruitingNCT06062238What this trial is testingStudy to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and AdultsWho this might be right forTuberculosis Gates Medical Research Institute 20,080
Early research (Phase 1)Study completedNCT01905215What this trial is testingStudy to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) VaccinesWho this might be right forInfections, Respiratory Syncytial Virus GlaxoSmithKline 128
Large-scale testing (Phase 3)Study completedNCT00224484What this trial is testingSafety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years OldWho this might be right forHerpes Simplex GlaxoSmithKline 5,960
Testing effectiveness (Phase 2)Study completedNCT00921947What this trial is testingComparative Safety and Immunogenicity of 1.0 µg Intramuscular (i.m.) and 2.0 µg Subcutaneous (s.c.) Dosing With VAX102 (M2e-flagellin) Universal Influenza Vaccine in Healthy AdultsWho this might be right forInfluenza VaxInnate Corporation 60
Post-approval studies (Phase 4)Study completedNCT00347958What this trial is testingDescriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® VaccineWho this might be right forTetanusDiphtheriaPertussis Sanofi Pasteur, a Sanofi Company 545
Early research (Phase 1)Study completedNCT01537185What this trial is testingPhase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy AdultsWho this might be right forPneumococcal Vaccines PATH Vaccine Solutions 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT05992935What this trial is testingStudy to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of AgeWho this might be right forNorovirus Acute Gastroenteritis ModernaTX, Inc. 1,407